Patent Assignment
Reel/Frame 014914/0536
Assignment of Assignor's Interest
Recorded: 2003-06-24
Pages: 7
Assignors
HEIDENREICH, OLAF
Executed: 2003-04-14
VORNLOCHER, HANS-PETER
Executed: 2003-04-08
KREUTZER, ROLAND
Executed: 2003-04-07
LIMMER, STEFAN
Executed: 2003-04-07
Assignee
RIBOPHARMA AG
FRITZ-HORNSCHUCH-STR. 9, KULMBACH, 95326, GERMANY
Covered Property
(1)
Double-Stranded Rna (Dsrna) and Method of Use for Inhibiting Expression of the Aml-1/MTG8 Fusion Gene
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Jun 22, 2004
From: RIBOPHARMA AG
To: ALNYLAM EUROPE AG
Reel/Frame 015488/0614 →
Assignment of Assignor's Interest
Aug 19, 2009
From: ALNYLAM EUROPE AG
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 023120/0064 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →